Industry Research Reports
Home > Reports > Chemical & Material > Fosfomycin Trometamol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Fosfomycin Trometamol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-01-16
Pages: 101 Pages
Report ld: 3475111
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Fosfomycin Trometamol Market Size(US$)
CAGR 2025-2031
3%
Market Size,2031
USD 41.6
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 34.8 million
Market Forecast in 2031(Value)
US$ 41.6 million
CAGR
3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Fosfomycin Trometamol was estimated to be worth US$ 33.9 million in 2024 and is forecast to a readjusted size of US$ 41.6 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.
Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.
Global Fosfomycin Trometamol key players include Zambon, Northesat Pharm, Hunan Huana Pharmaceuticals, etc. Global top three manufacturers hold a share over 60%.
China is the largest market, with a share over 60%, followed by Europe, with a share over 30 percent.
In terms of product, Fosfomycin Tromethamine Granules is the largest segment, with a share over 55%. And in terms of application, the largest application is Common Urinary Tract Infection, followed by Postoperative Urinary Tract Infection, Preoperative Prevention of Urinary Tract Infection, etc.
This report aims to provide a comprehensive presentation of the global market for Fosfomycin Trometamol, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fosfomycin Trometamol by region & country, by Type, and by Application.
The Fosfomycin Trometamol market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fosfomycin Trometamol.
MARKET SEGMENTATION
By Company
- Zambon
- Northesat Pharm
- Hunan Huana Pharmaceuticals
- Xunda Pharma
- FarmaSino Pharmaceutical
- Guilin Hwasun
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Fosfomycin Tromethamine Granules
- Fosfomycin Tromethamine Powder
Segment by Application
- Common Urinary Tract Infection
- Postoperative Urinary Tract Infection
- Preoperative Prevention of Urinary Tract Infection
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fosfomycin Trometamol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fosfomycin Trometamol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fosfomycin Trometamol in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Fosfomycin Trometamol Product Introduction
1.2 Global Fosfomycin Trometamol Market Size Forecast
1.2.1 Global Fosfomycin Trometamol Sales Value (2020-2031)
1.2.2 Global Fosfomycin Trometamol Sales Volume (2020-2031)
1.2.3 Global Fosfomycin Trometamol Sales Price (2020-2031)
1.3 Fosfomycin Trometamol Market Trends & Drivers
1.3.1 Fosfomycin Trometamol Industry Trends
1.3.2 Fosfomycin Trometamol Market Drivers & Opportunity
1.3.3 Fosfomycin Trometamol Market Challenges
1.3.4 Fosfomycin Trometamol Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fosfomycin Trometamol Players Revenue Ranking (2024)
2.2 Global Fosfomycin Trometamol Revenue by Company (2020-2025)
2.3 Global Fosfomycin Trometamol Players Sales Volume Ranking (2024)
2.4 Global Fosfomycin Trometamol Sales Volume by Company Players (2020-2025)
2.5 Global Fosfomycin Trometamol Average Price by Company (2020-2025)
2.6 Key Manufacturers Fosfomycin Trometamol Manufacturing Base and Headquarters
2.7 Key Manufacturers Fosfomycin Trometamol Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Fosfomycin Trometamol
2.9 Fosfomycin Trometamol Market Competitive Analysis
2.9.1 Fosfomycin Trometamol Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Fosfomycin Trometamol Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fosfomycin Trometamol as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fosfomycin Tromethamine Granules
3.1.2 Fosfomycin Tromethamine Powder
3.2 Global Fosfomycin Trometamol Sales Value by Type
3.2.1 Global Fosfomycin Trometamol Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Fosfomycin Trometamol Sales Value, by Type (2020-2031)
3.2.3 Global Fosfomycin Trometamol Sales Value, by Type (%) (2020-2031)
3.3 Global Fosfomycin Trometamol Sales Volume by Type
3.3.1 Global Fosfomycin Trometamol Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Fosfomycin Trometamol Sales Volume, by Type (2020-2031)
3.3.3 Global Fosfomycin Trometamol Sales Volume, by Type (%) (2020-2031)
3.4 Global Fosfomycin Trometamol Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Common Urinary Tract Infection
4.1.2 Postoperative Urinary Tract Infection
4.1.3 Preoperative Prevention of Urinary Tract Infection
4.1.4 Others
4.2 Global Fosfomycin Trometamol Sales Value by Application
4.2.1 Global Fosfomycin Trometamol Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Fosfomycin Trometamol Sales Value, by Application (2020-2031)
4.2.3 Global Fosfomycin Trometamol Sales Value, by Application (%) (2020-2031)
4.3 Global Fosfomycin Trometamol Sales Volume by Application
4.3.1 Global Fosfomycin Trometamol Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Fosfomycin Trometamol Sales Volume, by Application (2020-2031)
4.3.3 Global Fosfomycin Trometamol Sales Volume, by Application (%) (2020-2031)
4.4 Global Fosfomycin Trometamol Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Fosfomycin Trometamol Sales Value by Region
5.1.1 Global Fosfomycin Trometamol Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Fosfomycin Trometamol Sales Value by Region (2020-2025)
5.1.3 Global Fosfomycin Trometamol Sales Value by Region (2026-2031)
5.1.4 Global Fosfomycin Trometamol Sales Value by Region (%), (2020-2031)
5.2 Global Fosfomycin Trometamol Sales Volume by Region
5.2.1 Global Fosfomycin Trometamol Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Fosfomycin Trometamol Sales Volume by Region (2020-2025)
5.2.3 Global Fosfomycin Trometamol Sales Volume by Region (2026-2031)
5.2.4 Global Fosfomycin Trometamol Sales Volume by Region (%), (2020-2031)
5.3 Global Fosfomycin Trometamol Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Fosfomycin Trometamol Sales Value, 2020-2031
5.4.2 North America Fosfomycin Trometamol Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Fosfomycin Trometamol Sales Value, 2020-2031
5.5.2 Europe Fosfomycin Trometamol Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Fosfomycin Trometamol Sales Value, 2020-2031
5.6.2 Asia Pacific Fosfomycin Trometamol Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Fosfomycin Trometamol Sales Value, 2020-2031
5.7.2 South America Fosfomycin Trometamol Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Fosfomycin Trometamol Sales Value, 2020-2031
5.8.2 Middle East & Africa Fosfomycin Trometamol Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fosfomycin Trometamol Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Fosfomycin Trometamol Sales Value
6.2.1 Key Countries/Regions Fosfomycin Trometamol Sales Value, 2020-2031
6.2.2 Key Countries/Regions Fosfomycin Trometamol Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Fosfomycin Trometamol Sales Value, 2020-2031
6.3.2 United States Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Fosfomycin Trometamol Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Fosfomycin Trometamol Sales Value, 2020-2031
6.4.2 Europe Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Fosfomycin Trometamol Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Fosfomycin Trometamol Sales Value, 2020-2031
6.5.2 China Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
6.5.3 China Fosfomycin Trometamol Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Fosfomycin Trometamol Sales Value, 2020-2031
6.6.2 Japan Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Fosfomycin Trometamol Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Fosfomycin Trometamol Sales Value, 2020-2031
6.7.2 South Korea Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Fosfomycin Trometamol Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Fosfomycin Trometamol Sales Value, 2020-2031
6.8.2 Southeast Asia Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Fosfomycin Trometamol Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Fosfomycin Trometamol Sales Value, 2020-2031
6.9.2 India Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
6.9.3 India Fosfomycin Trometamol Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Zambon
7.1.1 Zambon Company Information
7.1.2 Zambon Introduction and Business Overview
7.1.3 Zambon Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Zambon Fosfomycin Trometamol Product Offerings
7.1.5 Zambon Recent Development
7.2 Northesat Pharm
7.2.1 Northesat Pharm Company Information
7.2.2 Northesat Pharm Introduction and Business Overview
7.2.3 Northesat Pharm Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Northesat Pharm Fosfomycin Trometamol Product Offerings
7.2.5 Northesat Pharm Recent Development
7.3 Hunan Huana Pharmaceuticals
7.3.1 Hunan Huana Pharmaceuticals Company Information
7.3.2 Hunan Huana Pharmaceuticals Introduction and Business Overview
7.3.3 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Product Offerings
7.3.5 Hunan Huana Pharmaceuticals Recent Development
7.4 Xunda Pharma
7.4.1 Xunda Pharma Company Information
7.4.2 Xunda Pharma Introduction and Business Overview
7.4.3 Xunda Pharma Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Xunda Pharma Fosfomycin Trometamol Product Offerings
7.4.5 Xunda Pharma Recent Development
7.5 FarmaSino Pharmaceutical
7.5.1 FarmaSino Pharmaceutical Company Information
7.5.2 FarmaSino Pharmaceutical Introduction and Business Overview
7.5.3 FarmaSino Pharmaceutical Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 FarmaSino Pharmaceutical Fosfomycin Trometamol Product Offerings
7.5.5 FarmaSino Pharmaceutical Recent Development
7.6 Guilin Hwasun
7.6.1 Guilin Hwasun Company Information
7.6.2 Guilin Hwasun Introduction and Business Overview
7.6.3 Guilin Hwasun Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Guilin Hwasun Fosfomycin Trometamol Product Offerings
7.6.5 Guilin Hwasun Recent Development
8 Industry Chain Analysis
8.1 Fosfomycin Trometamol Industrial Chain
8.2 Fosfomycin Trometamol Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Fosfomycin Trometamol Sales Model
8.5.2 Sales Channel
8.5.3 Fosfomycin Trometamol Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Fosfomycin Trometamol Market Trends
Table 2. Fosfomycin Trometamol Market Drivers & Opportunity
Table 3. Fosfomycin Trometamol Market Challenges
Table 4. Fosfomycin Trometamol Market Restraints
Table 5. Global Fosfomycin Trometamol Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Fosfomycin Trometamol Revenue Market Share by Company (2020-2025)
Table 7. Global Fosfomycin Trometamol Sales Volume by Company (2020-2025) & (MT)
Table 8. Global Fosfomycin Trometamol Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Fosfomycin Trometamol Price by Company (2020-2025) & (USD/Kg)
Table 10. Key Manufacturers Fosfomycin Trometamol Manufacturing Base and Headquarters
Table 11. Key Manufacturers Fosfomycin Trometamol Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Fosfomycin Trometamol
Table 13. Global Fosfomycin Trometamol Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fosfomycin Trometamol as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Fosfomycin Trometamol Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Fosfomycin Trometamol Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Fosfomycin Trometamol Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Fosfomycin Trometamol Sales Market Share in Value by Type (2020-2025)
Table 20. Global Fosfomycin Trometamol Sales Market Share in Value by Type (2026-2031)
Table 21. Global Fosfomycin Trometamol Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
Table 22. Global Fosfomycin Trometamol Sales Volume by Type (2020-2025) & (MT)
Table 23. Global Fosfomycin Trometamol Sales Volume by Type (2026-2031) & (MT)
Table 24. Global Fosfomycin Trometamol Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Fosfomycin Trometamol Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Fosfomycin Trometamol Price by Type (2020-2025) & (USD/Kg)
Table 27. Global Fosfomycin Trometamol Price by Type (2026-2031) & (USD/Kg)
Table 28. Global Fosfomycin Trometamol Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Fosfomycin Trometamol Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Fosfomycin Trometamol Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Fosfomycin Trometamol Sales Market Share in Value by Application (2020-2025)
Table 32. Global Fosfomycin Trometamol Sales Market Share in Value by Application (2026-2031)
Table 33. Global Fosfomycin Trometamol Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
Table 34. Global Fosfomycin Trometamol Sales Volume by Application (2020-2025) & (MT)
Table 35. Global Fosfomycin Trometamol Sales Volume by Application (2026-2031) & (MT)
Table 36. Global Fosfomycin Trometamol Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Fosfomycin Trometamol Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Fosfomycin Trometamol Price by Application (2020-2025) & (USD/Kg)
Table 39. Global Fosfomycin Trometamol Price by Application (2026-2031) & (USD/Kg)
Table 40. Global Fosfomycin Trometamol Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Fosfomycin Trometamol Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Fosfomycin Trometamol Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Fosfomycin Trometamol Sales Value by Region (2020-2025) & (%)
Table 44. Global Fosfomycin Trometamol Sales Value by Region (2026-2031) & (%)
Table 45. Global Fosfomycin Trometamol Sales Volume by Region (MT): 2020 VS 2024 VS 2031
Table 46. Global Fosfomycin Trometamol Sales Volume by Region (2020-2025) & (MT)
Table 47. Global Fosfomycin Trometamol Sales Volume by Region (2026-2031) & (MT)
Table 48. Global Fosfomycin Trometamol Sales Volume by Region (2020-2025) & (%)
Table 49. Global Fosfomycin Trometamol Sales Volume by Region (2026-2031) & (%)
Table 50. Global Fosfomycin Trometamol Average Price by Region (2020-2025) & (USD/Kg)
Table 51. Global Fosfomycin Trometamol Average Price by Region (2026-2031) & (USD/Kg)
Table 52. Key Countries/Regions Fosfomycin Trometamol Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Fosfomycin Trometamol Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Fosfomycin Trometamol Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Fosfomycin Trometamol Sales Volume, (2020-2025) & (MT)
Table 56. Key Countries/Regions Fosfomycin Trometamol Sales Volume, (2026-2031) & (MT)
Table 57. Zambon Company Information
Table 58. Zambon Introduction and Business Overview
Table 59. Zambon Fosfomycin Trometamol Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 60. Zambon Fosfomycin Trometamol Product Offerings
Table 61. Zambon Recent Development
Table 62. Northesat Pharm Company Information
Table 63. Northesat Pharm Introduction and Business Overview
Table 64. Northesat Pharm Fosfomycin Trometamol Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 65. Northesat Pharm Fosfomycin Trometamol Product Offerings
Table 66. Northesat Pharm Recent Development
Table 67. Hunan Huana Pharmaceuticals Company Information
Table 68. Hunan Huana Pharmaceuticals Introduction and Business Overview
Table 69. Hunan Huana Pharmaceuticals Fosfomycin Trometamol Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 70. Hunan Huana Pharmaceuticals Fosfomycin Trometamol Product Offerings
Table 71. Hunan Huana Pharmaceuticals Recent Development
Table 72. Xunda Pharma Company Information
Table 73. Xunda Pharma Introduction and Business Overview
Table 74. Xunda Pharma Fosfomycin Trometamol Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Xunda Pharma Fosfomycin Trometamol Product Offerings
Table 76. Xunda Pharma Recent Development
Table 77. FarmaSino Pharmaceutical Company Information
Table 78. FarmaSino Pharmaceutical Introduction and Business Overview
Table 79. FarmaSino Pharmaceutical Fosfomycin Trometamol Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. FarmaSino Pharmaceutical Fosfomycin Trometamol Product Offerings
Table 81. FarmaSino Pharmaceutical Recent Development
Table 82. Guilin Hwasun Company Information
Table 83. Guilin Hwasun Introduction and Business Overview
Table 84. Guilin Hwasun Fosfomycin Trometamol Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. Guilin Hwasun Fosfomycin Trometamol Product Offerings
Table 86. Guilin Hwasun Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Fosfomycin Trometamol Downstream Customers
Table 90. Fosfomycin Trometamol Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Fosfomycin Trometamol Product Picture
Figure 2. Global Fosfomycin Trometamol Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Fosfomycin Trometamol Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Fosfomycin Trometamol Sales Volume (2020-2031) & (MT)
Figure 5. Global Fosfomycin Trometamol Sales Price (2020-2031) & (USD/Kg)
Figure 6. Fosfomycin Trometamol Report Years Considered
Figure 7. Global Fosfomycin Trometamol Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Fosfomycin Trometamol Players Sales Volume Ranking (2024) & (MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Fosfomycin Trometamol Revenue in 2024
Figure 10. Fosfomycin Trometamol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Fosfomycin Tromethamine Granules Picture
Figure 12. Fosfomycin Tromethamine Powder Picture
Figure 13. Global Fosfomycin Trometamol Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Fosfomycin Trometamol Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Fosfomycin Trometamol Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
Figure 16. Global Fosfomycin Trometamol Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Fosfomycin Trometamol Price by Type (2020-2031) & (USD/Kg)
Figure 18. Product Picture of Common Urinary Tract Infection
Figure 19. Product Picture of Postoperative Urinary Tract Infection
Figure 20. Product Picture of Preoperative Prevention of Urinary Tract Infection
Figure 21. Product Picture of Others
Figure 22. Global Fosfomycin Trometamol Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Fosfomycin Trometamol Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Fosfomycin Trometamol Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
Figure 25. Global Fosfomycin Trometamol Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Fosfomycin Trometamol Price by Application (2020-2031) & (USD/Kg)
Figure 27. North America Fosfomycin Trometamol Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Fosfomycin Trometamol Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Fosfomycin Trometamol Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Fosfomycin Trometamol Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Fosfomycin Trometamol Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Fosfomycin Trometamol Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Fosfomycin Trometamol Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Fosfomycin Trometamol Sales Volume (%), (2020-2031)
Figure 39. United States Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Fosfomycin Trometamol Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Fosfomycin Trometamol Sales Value by Application (%), 2024 VS 2031
Figure 45. China Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
Figure 47. China Fosfomycin Trometamol Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Fosfomycin Trometamol Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Fosfomycin Trometamol Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Fosfomycin Trometamol Sales Value by Application (%), 2024 VS 2031
Figure 57. India Fosfomycin Trometamol Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Fosfomycin Trometamol Sales Value by Type (%), 2024 VS 2031
Figure 59. India Fosfomycin Trometamol Sales Value by Application (%), 2024 VS 2031
Figure 60. Fosfomycin Trometamol Industrial Chain
Figure 61. Fosfomycin Trometamol Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Fosfomycin Trometamol in 2025?
The global market size of Fosfomycin Trometamol in 2025 was 34.8 Million USD.
What was the global market size of Fosfomycin Trometamol in 2031?
Which companies rank high in the global Fosfomycin Trometamol market?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Fosfomycin Trometamol market size from 2025 to 2031?
Related Reports
Global Fosfomycin Trometamol Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Fosfomycin Trometamol market is projected to grow from US$ 43.00 million in 2025 to US$ 53.73 million by 2032, at a CAGR of 3.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-05-02
Pages: 138
USD 4900.00
(Single User License)
Global Fosfomycin Trometamol Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Fosfomycin Trometamol market size was US$ 43.00 million in 2025 and is forecast to reach a readjusted size of US$ 53.73 million by 2032 with a CAGR of 3.0% during the forecast period 2026-2032.
Published Date: 2026-05-02
Pages: 129
USD 4250.00
(Single User License)
Global Fosfomycin Trometamol Market Research Report 2026
The global Fosfomycin Trometamol market was valued at US$ 43.00 million in 2025 and is anticipated to reach US$ 53.73 million by 2032, at a CAGR of 3.0% from 2026 to 2032.
Published Date: 2026-05-02
Pages: 126
USD 2900.00
(Single User License)
Fosfomycin Trometamol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Fosfomycin Trometamol was estimated to be worth US$ 43.00 million in 2025 and is projected to reach US$ 53.73 million, growing at a CAGR of 3.0% from 2026 to 2032.
Published Date: 2026-05-02
Pages: 128
USD 3950.00
(Single User License)
Global Fosfomycin Trometamol Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Fosfomycin Trometamol market is projected to grow from US$ 33.9 million in 2024 to US$ 41.6 million by 2031, at a CAGR of 3.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 142
USD 4900.00
(Single User License)
Fosfomycin Trometamol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Fosfomycin Trometamol was estimated to be worth US$ 33.9 million in 2024 and is forecast to a readjusted size of US$ 41.6 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.
Published Date: 2025-05-30
Pages: 102
USD 3950.00
(Single User License)
Global Fosfomycin Trometamol Market Insights, Forecast to 2031
The global Fosfomycin Trometamol market is projected to grow from US$ 34.8 million in 2025 to US$ 41.6 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.0% during the forecast period.
Published Date: 2025-05-30
Pages: 146
USD 4900.00
(Single User License)
Global Fosfomycin Trometamol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Fosfomycin Trometamol market size was US$ 33.9 million in 2024 and is forecast to a readjusted size of US$ 41.6 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.
Published Date: 2025-05-30
Pages: 76
USD 4250.00
(Single User License)
Global Fosfomycin Trometamol Market Research Report 2025
The global market for Fosfomycin Trometamol was valued at US$ 33.9 million in the year 2024 and is projected to reach a revised size of US$ 41.6 million by 2031, growing at a CAGR of 3.0% during the forecast period.
Published Date: 2025-05-30
Pages: 88
USD 2900.00
(Single User License)
Global Fosfomycin Trometamol Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Fosfomycin Trometamol was estimated to be worth US$ 33.9 million and is forecast to reach approximately US$ 41.6 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 122
USD 5900.00
(Single User License)
Global Fosfomycin Trometamol Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Fosfomycin Trometamol market is projected to grow from US$ 43.00 million in 2025 to US$ 53.73 million by 2032, at a CAGR of 3.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-05-02
Pages: 138
USD 4900.00 (Single User License)Global Fosfomycin Trometamol Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Fosfomycin Trometamol market size was US$ 43.00 million in 2025 and is forecast to reach a readjusted size of US$ 53.73 million by 2032 with a CAGR of 3.0% during the forecast period 2026-2032.
Published: 2026-05-02
Pages: 129
USD 4250.00 (Single User License)Global Fosfomycin Trometamol Market Research Report 2026
The global Fosfomycin Trometamol market was valued at US$ 43.00 million in 2025 and is anticipated to reach US$ 53.73 million by 2032, at a CAGR of 3.0% from 2026 to 2032.
Published: 2026-05-02
Pages: 126
USD 2900.00 (Single User License)Fosfomycin Trometamol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Fosfomycin Trometamol was estimated to be worth US$ 43.00 million in 2025 and is projected to reach US$ 53.73 million, growing at a CAGR of 3.0% from 2026 to 2032.
Published: 2026-05-02
Pages: 128
USD 3950.00 (Single User License)Global Fosfomycin Trometamol Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Fosfomycin Trometamol market is projected to grow from US$ 33.9 million in 2024 to US$ 41.6 million by 2031, at a CAGR of 3.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 142
USD 4900.00 (Single User License)Fosfomycin Trometamol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Fosfomycin Trometamol was estimated to be worth US$ 33.9 million in 2024 and is forecast to a readjusted size of US$ 41.6 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.
Published: 2025-05-30
Pages: 102
USD 3950.00 (Single User License)Global Fosfomycin Trometamol Market Insights, Forecast to 2031
The global Fosfomycin Trometamol market is projected to grow from US$ 34.8 million in 2025 to US$ 41.6 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.0% during the forecast period.
Published: 2025-05-30
Pages: 146
USD 4900.00 (Single User License)Global Fosfomycin Trometamol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Fosfomycin Trometamol market size was US$ 33.9 million in 2024 and is forecast to a readjusted size of US$ 41.6 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.
Published: 2025-05-30
Pages: 76
USD 4250.00 (Single User License)Global Fosfomycin Trometamol Market Research Report 2025
The global market for Fosfomycin Trometamol was valued at US$ 33.9 million in the year 2024 and is projected to reach a revised size of US$ 41.6 million by 2031, growing at a CAGR of 3.0% during the forecast period.
Published: 2025-05-30
Pages: 88
USD 2900.00 (Single User License)Global Fosfomycin Trometamol Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Fosfomycin Trometamol was estimated to be worth US$ 33.9 million and is forecast to reach approximately US$ 41.6 million by 2031 with a CAGR of 3.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 122
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now